A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
Clinical trial NCT05551936 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05551936
- Sponsor
- Vaishalee Kenkre
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-26
- Primary completion
- 2026-05-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.